How can Proteliv(Oxymatrine) treat Hepatitis B and C?
Proteliv(oxymatrine) has been approved in China to treat chronic hepatitis B and chronic hepatitis C. According to Chinese clinical research in relation to viral hepatitis, Proteliv(oxymatrine) appears to inhibit the viral replication, reduce destruction of liver cells, protect against fibrosis, and also promote the flow of bile. These effects were comparable to those attained with interferon therapy, except that adverse reactions were avoided.